Building on dendritic cell subsets to improve cancer vaccines

Current Opinion in Immunology

Volumn 22, Issue 2, 2010, Pages 258-263

  Palucka, Karolina ^a,b,c   Ueno, Hideki ^a   Zurawski, Gerard ^a   Fay, Joseph ^a,c   Banchereau, Jacques ^a,b,c  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CANCER VACCINE; CD14 ANTIGEN; DENDRITIC CELL VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 4; MELANOMA ANTIGEN; POLYINOSINIC POLYCYTIDYLIC ACID; TUMOR NECROSIS FACTOR;

ACTIVE IMMUNIZATION; ADOPTIVE TRANSFER; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; BONE MARROW CELL; CANCER CONTROL; CANCER GROWTH; CANCER IMMUNIZATION; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CLINICAL TRIAL; DENDRITIC CELL; EFFECTOR CELL; HEAD AND NECK CANCER; HELPER CELL; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL MONITORING; LANGERHANS CELL; LYMPHOCYTE PROLIFERATION; MALIGNANT NEOPLASTIC DISEASE; MEMORY T LYMPHOCYTE; NONHUMAN; PASSIVE IMMUNIZATION; REGULATORY T LYMPHOCYTE; REVIEW; SURVIVAL TIME; T LYMPHOCYTE SUBPOPULATION; TREATMENT RESPONSE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CANCER VACCINES; DENDRITIC CELLS; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 77951259112     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2010.02.010     Document Type: Review

References (37)

1. Steinman R.M., Banchereau J. Taking dendritic cells into medicine. Nature 2007, 449:419-426.
2. Palucka A.K., Ueno H., Fay J.W., Banchereau J. Taming cancer by inducing immunity via dendritic cells. Immunol Rev 2007, 220:129-150.
3. Palucka A.K., Ueno H., Connolly J., Kerneis-Norvell F., Blanck J.P., Johnston D.A., Fay J., Banchereau J. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity. J Immunother 2006, 29:545-557.
4. Berard F., Blanco P., Davoust J., Neidhart-Berard E.M., Nouri-Shirazi M., Taquet N., Rimoldi D., Cerottini J.C., Banchereau J., Palucka A.K. Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J Exp Med 2000, 192:1535-1544.
5. Appay V., Douek D.C., Price D.A. CD8+ T cell efficacy in vaccination and disease. Nat Med 2008, 14:623-628.
6. Harlin H., Meng Y., Peterson A.C., Zha Y., Tretiakova M., Slingluff C., McKee M., Gajewski T.F. Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. Cancer Res 2009, 69:3077-3085.
7. Mullins I.M., Slingluff C.L., Lee J.K., Garbee C.F., Shu J., Anderson S.G., Mayer M.E., Knaus W.A., Mullins D.W. CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease. Cancer Res 2004, 64:7697-7701.
8. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009, 9:162-174.
9. Menetrier-Caux C., Gobert M., Caux C. Differences in tumor regulatory T-cell localization and activation status impact patient outcome. Cancer Res 2009, 69:7895-7898.
10. Vence L., Palucka A.K., Fay J.W., Ito T., Liu Y.J., Banchereau J., Ueno H. Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma. Proc Natl Acad Sci U S A 2007, 104:20884-20889.
11. Merad M., Ginhoux F., Collin M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 2008, 8:935-947.
12. Nestle F.O., Di Meglio P., Qin J.Z., Nickoloff B.J. Skin immune sentinels in health and disease. Nat Rev Immunol 2009, 9:679-691.
13. + dermal dendritic cells. Immunity 2008, 29:497-510.
14. Caux C., Massacrier C., Vanbervliet B., Dubois B., Durand I., Cella M., Lanzavecchia A., Banchereau J. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha. II. Functional analysis. Blood 1997, 90:1458-1470.
15. Fazilleau N., Mark L., McHeyzer-Williams L.J., McHeyzer-Williams M.G. Follicular helper T cells: lineage and location. Immunity 2009, 30:324-335.
16. Schmitt N., Morita R., Bourdery L., Bentebibel S.E., Zurawski S.M., Banchereau J., Ueno H. Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity 2009, 31:158-169.
17. Germain R.N., Bajenoff M., Castellino F., Chieppa M., Egen J.G., Huang A.Y., Ishii M., Koo L.Y., Qi H. Making friends in out-of-the-way places: how cells of the immune system get together and how they conduct their business as revealed by intravital imaging. Immunol Rev 2008, 221:163-181.
18. Motzer R.J., Rakhit A., Thompson J.A., Nemunaitis J., Murphy B.A., Ellerhorst J., Schwartz L.H., Berg W.J., Bukowski R.M. Randomized multicenter phase II trial of subcutaneous recombinant human interleukin-12 versus interferon-alpha 2a for patients with advanced renal cell carcinoma. J Interferon Cytokine Res 2001, 21:257-263.
19. Cheever M.A. Twelve immunotherapy drugs that could cure cancers. Immunol Rev 2008, 222:357-368.
20. van Herpen C.M., van der Voort R., van der Laak J.A., Klasen I.S., de Graaf A.O., van Kempen L.C., de Vries I.J., Boer T.D., Dolstra H., Torensma R., et al. Intratumoral rhIL-12 administration in head and neck squamous cell carcinoma patients induces B cell activation. Int J Cancer 2008, 123:2354-2361.
21. Mohamadzadeh M., Berard F., Essert G., Chalouni C., Pulendran B., Davoust J., Bridges G., Palucka A.K., Banchereau J. Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J Exp Med 2001, 194:1013-1020.
22. Dubsky P., Saito H., Leogier M., Dantin C., Connolly J.E., Banchereau J., Palucka A.K. IL-15-induced human DC efficiently prime melanoma-specific naive CD8(+) T cells to differentiate into CTL. Eur J Immunol 2007, 37:1678-1690.
23. Mailliard R.B., Wankowicz-Kalinska A., Cai Q., Wesa A., Hilkens C.M., Kapsenberg M.L., Kirkwood J.M., Storkus W.J., Kalinski P. Alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res 2004, 64:5934-5937.
24. Bonifaz L., Bonnyay D., Mahnke K., Rivera M., Nussenzweig M.C., Steinman R.M. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 2002, 196:1627-1638.
25. Bonifaz L.C., Bonnyay D.P., Charalambous A., Darguste D.I., Fujii S., Soares H., Brimnes M.K., Moltedo B., Moran T.M., Steinman R.M. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med 2004, 199:815-824.
26. Caminschi I., Lahoud M.H., Shortman K. Enhancing immune responses by targeting antigen to DC. Eur J Immunol 2009, 39:931-938.
27. Flacher V., Douillard P., Ait-Yahia S., Stoitzner P., Clair-Moninot V., Romani N., Saeland S. Expression of langerin/CD207 reveals dendritic cell heterogeneity between inbred mouse strains. Immunology 2008, 123:339-347.
28. Flacher V., Sparber F., Tripp C.H., Romani N., Stoitzner P. Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy. Cancer Immunol Immunother 2009, 58:1137-1147.
29. Wei H., Wang S., Zhang D., Hou S., Qian W., Li B., Guo H., Kou G., He J., Wang H., et al. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice. Clin Cancer Res 2009, 15:4612-4621.
30. Idoyaga J., Cheong C., Suda K., Suda N., Kim J.Y., Lee H., Park C.G., Steinman R.M. Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo. J Immunol 2008, 180:3647-3650.
31. Manicassamy S., Ravindran R., Deng J., Oluoch H., Denning T.L., Kasturi S.P., Rosenthal K.M., Evavold B.D., Pulendran B. Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat Med 2009, 15:401-409.
32. Brown G.D. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 2006, 6:33-43.
33. Figdor C.G., van Kooyk Y., Adema G.J. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2002, 2:77-84.
34. Jeannin P., Bottazzi B., Sironi M., Doni A., Rusnati M., Presta M., Maina V., Magistrelli G., Haeuw J.F., Hoeffel G., et al. Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity 2005, 22:551-560.
35. Delneste Y., Magistrelli G., Gauchat J., Haeuw J., Aubry J., Nakamura K., Kawakami-Honda N., Goetsch L., Sawamura T., Bonnefoy J., et al. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 2002, 17:353-362.
36. Geijtenbeek T.B., van Vliet S.J., Engering A., t Hart B.A., van Kooyk Y. Self- and nonself-recognition by C-type lectins on dendritic cells. Annu Rev Immunol 2004, 22:33-54.
37. Caparros E., Munoz P., Sierra-Filardi E., Serrano-Gomez D., Puig-Kroger A., Rodriguez-Fernandez J.L., Mellado M., Sancho J., Zubiaur M., Corbi A.L. DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production. Blood 2006, 107:3950-3958.